Please assess the completion status of the following clinical trial:

Trial Title: Circulating Adenosine Levels Before and After Intravenous (IV) Persantine

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_CONTROL
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Subjects with or without coronary artery disease undergoing a Persantine nuclear stress test~Exclusion Criteria:~* Oral persantine use within 24 hours~* Second or third degree AV block, or sick sinus syndrome without a functioning pacemaker~* Active asthma or bronchospasm~* Those with end-stage liver disease such as cirrhosis or active hepatitis such as \> 5 fold liver enzyme elevation will not be included~* Anemia (Hct \< 30)~* Myocardial infarction within 30 days~* Severe left ventricular dysfunction (EF \< 30%)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- undergoing persantine stress test (Type: None): None

Based on this trial design, predict the completion outcome and termination type (if applicable).